Cargando…

First-in-human intraoperative near-infrared fluorescence imaging of glioblastoma using cetuximab-IRDye800

INTRODUCTION: Maximizing extent of surgical resection with the least morbidity remains critical for survival in glioblastoma patients, and we hypothesize that it can be improved by enhancements in intraoperative tumor detection. In a clinical study, we determined if therapeutic antibodies could be r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miller, Sarah E., Tummers, Willemieke S., Teraphongphom, Nutte, van den Berg, Nynke S., Hasan, Alifia, Ertsey, Robert D., Nagpal, Seema, Recht, Lawrence D., Plowey, Edward D., Vogel, Hannes, Harsh, Griffith R., Grant, Gerald A., Li, Gordon H., Rosenthal, Eben L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2018
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031450/ https://www.ncbi.nlm.nih.gov/pubmed/29623552 http://dx.doi.org/10.1007/s11060-018-2854-0

Ejemplares similares

Safety of panitumumab-IRDye800CW and cetuximab-IRDye800CW for fluorescence-guided surgical navigation in head and neck cancers
por: Gao, Rebecca W., et al.
Publicado: (2018)

EGFR-targeted intraoperative fluorescence imaging detects high-grade glioma with panitumumab-IRDye800 in a phase 1 clinical trial
por: Zhou, Quan, et al.
Publicado: (2021)

Targeting intracranial patient-derived glioblastoma (GBM) with a NIR-I fluorescent immunoconjugate for facilitating its image-guided resection
por: Hettie, Kenneth S., et al.
Publicado: (2020)

Near-Infrared Fluorescence Imaging of EGFR-Overexpressing Tumors in the Mouse Xenograft Model Using scFv-IRDye800CW and Cetuximab-IRDye800CW
por: Amini, Abolfazl, et al.
Publicado: (2022)

Metastatic and sentinel lymph node mapping using intravenously delivered Panitumumab-IRDye800CW
por: Krishnan, Giri, et al.
Publicado: (2021)

Multimodal image-guided surgery of HER2-positive breast cancer using [(111)In]In-DTPA-trastuzumab-IRDye800CW in an orthotopic breast tumor model
por: Deken, Marion M., et al.
Publicado: (2019)

The Use of Panitumumab-IRDye800CW in a Novel Murine Model for Conjunctival Squamous Cell Carcinoma
por: Youn, Gun Min, et al.
Publicado: (2022)

Specimen mapping in head and neck cancer using fluorescence imaging
por: Teraphongphom, Nutte, et al.
Publicado: (2017)

Fluorescence-guided craniotomy of glioblastoma using panitumumab-IRDye800
por: Zhou, Quan, et al.
Publicado: (2022)

In-vivo optical imaging in head and neck oncology: basic principles, clinical applications and future directions
por: Wu, Chenzhou, et al.
Publicado: (2018)

Towards Photodynamic Image-Guided Surgery of Head and Neck Tumors: Photodynamic Priming Improves Delivery and Diagnostic Accuracy of Cetuximab-IRDye800CW
por: Bhandari, Chanda, et al.
Publicado: (2022)

Single-Dose Intravenous Toxicity Study of IRDye 800CW in Sprague-Dawley Rats
por: Marshall, Milton V., et al.
Publicado: (2010)

Pre-clinical study of IRDye800CW-nimotuzumab formulation, stability, pharmacokinetics, and safety
por: Bernhard, Wendy, et al.
Publicado: (2021)

Bevacizumab Improves Quality of Life in Patients with Recurrent Glioblastoma
por: Nagpal, Seema, et al.
Publicado: (2011)

Inert coupling of IRDye800CW to monoclonal antibodies for clinical optical imaging of tumor targets
por: Cohen, Ruth, et al.
Publicado: (2011)

Near infrared fluorescence imaging of EGFR expression in vivo using IRDye800CW-nimotuzumab
por: Bernhard, Wendy, et al.
Publicado: (2017)

Detection of Tumour-Targeted IRDye800CW Tracer with Commercially Available Laparoscopic Surgical Systems
por: Sikkenk, Daan J., et al.
Publicado: (2023)

Anti-GD2-IRDye800CW as a targeted probe for fluorescence-guided surgery in neuroblastoma
por: Wellens, Lianne M., et al.
Publicado: (2020)

Tumor-Specific Imaging with Angiostamp800 or Bevacizumab-IRDye 800CW Improves Fluorescence-Guided Surgery over Indocyanine Green in Peritoneal Carcinomatosis
por: Josserand, Véronique, et al.
Publicado: (2022)

Targeted Optical Imaging of the Glucagonlike Peptide 1 Receptor Using Exendin-4-IRDye 800CW
por: Boss, Marti, et al.
Publicado: (2020)

Improved Multimodal Tumor Necrosis Imaging with IRDye800CW-DOTA Conjugated to an Albumin-Binding Domain
por: Stroet, Marcus C. M., et al.
Publicado: (2022)

Nanocolloidal albumin-IRDye 800CW: a near-infrared fluorescent tracer with optimal retention in the sentinel lymph node
por: Heuveling, Derrek A., et al.
Publicado: (2012)

Manufacture of IRDye800CW-coupled Fe(3)O(4 )nanoparticles and their applications in cell labeling and in vivo imaging
por: Hou, Yong, et al.
Publicado: (2010)

A novel method to quantify IRDye800CW fluorescent antibody probes ex vivo in tissue distribution studies
por: Oliveira, Sabrina, et al.
Publicado: (2012)

Near-Infrared Molecular Imaging of Glioblastoma by Miltuximab(®)-IRDye800CW as a Potential Tool for Fluorescence-Guided Surgery
por: Polikarpov, Dmitry M., et al.
Publicado: (2020)

In Vivo Evaluation of Gallium-68-Labeled IRDye800CW as a Necrosis Avid Contrast Agent in Solid Tumors
por: Stroet, Marcus C. M., et al.
Publicado: (2021)

Resection and survival data from a clinical trial of glioblastoma multiforme‐specific IRDye800‐BBN fluorescence‐guided surgery
por: He, Kunshan, et al.
Publicado: (2020)

IRDye800CW labeled uPAR-targeting peptide for fluorescence-guided glioblastoma surgery: Preclinical studies in orthotopic xenografts
por: Kurbegovic, Sorel, et al.
Publicado: (2021)

Recommendations for reporting on emerging optical imaging agents to promote clinical approval
por: Tummers, Willemieke S., et al.
Publicado: (2018)

First-in-human study of PET and optical dual-modality image-guided surgery in glioblastoma using (68)Ga-IRDye800CW-BBN
por: Li, Deling, et al.
Publicado: (2018)

Necrosis binding of Ac-Lys(0)(IRDye800CW)-Tyr(3)-octreotate: a consequence from cyanine-labeling of small molecules
por: Stroet, Marcus C. M., et al.
Publicado: (2021)

Preclinical assessment of IRDye800CW‐labeled gastrin‐releasing peptide receptor‐targeting peptide for near infrared‐II imaging of brain malignancies
por: Zhang, Yuan, et al.
Publicado: (2023)

Imaging the distribution of an antibody-drug conjugate constituent targeting mesothelin with (89)Zr and IRDye 800CW in mice bearing human pancreatic tumor xenografts
por: ter Weele, Eva J., et al.
Publicado: (2015)

Optical molecular imaging can differentiate metastatic from benign lymph nodes in head and neck cancer
por: Nishio, Naoki, et al.
Publicado: (2019)

Evaluation of Ac-Lys(0)(IRDye800CW)Tyr(3)-octreotate as a novel tracer for SSTR(2)-targeted molecular fluorescence guided surgery in meningioma
por: Dijkstra, Bianca M., et al.
Publicado: (2021)

Improved resection and prolonged overall survival with PD-1-IRDye800CW fluorescence probe-guided surgery and PD-1 adjuvant immunotherapy in 4T1 mouse model
por: Du, Yang, et al.
Publicado: (2017)

Correction to: Evaluation of Ac-Lys(0)(IRDye800CW)Tyr(3)-octreotate as a novel tracer for SSTR(2)-targeted molecular fluorescence guided surgery in meningioma
por: Dijkstra, Bianca M., et al.
Publicado: (2021)

Fluorescence molecular imaging using cetuximab‐800CW in cutaneous squamous cell carcinoma surgery: a proof‐of‐concept study
por: Vonk, Jasper, et al.
Publicado: (2022)

Advances in the management of glioblastoma: the role of temozolomide and MGMT testing
por: Thomas, Reena P, et al.
Publicado: (2012)

In Vivo Fluorescence Immunohistochemistry: Localization of Fluorescently Labeled Cetuximab in Squamous Cell Carcinomas
por: de Boer, Esther, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_r612cbaqiqhmj1h2bjutno0esd